S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
S&P 500   5,078.18
DOW   38,972.41
QQQ   437.60
bluebird bio stock is ripe for a 400% institutional short squeeze
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 lithium stocks to ride a multi-year cycle
Goldman upgraded Nvidia stock, one metric says it could go higher
Critical asset just had biggest fall on record (Ad)
Autozone stock price is still in the rally zone
Salesforce stock got a boost. Is it growing off the Nvidia boom?
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Closing prices for crude oil, gold and other commodities
New highs are coming for Lowe’s stock despite mixed results
NASDAQ:MDGS

Medigus (MDGS) Stock Price, News & Analysis

$2.72
0.00 (0.00%)
(As of 02/27/2024 ET)
Today's Range
$2.70
$2.90
50-Day Range
$2.72
$3.83
52-Week Range
$2.65
$7.17
Volume
12,522 shs
Average Volume
5,245 shs
Market Capitalization
$4.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Medigus MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.26% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.00mentions of Medigus in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.23 out of 5 stars


MDGS stock logo

About Medigus Stock (NASDAQ:MDGS)

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

MDGS Stock Price History

MDGS Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Medigus Ltd. (MDGS)
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Medigus Goes a-Buyin’, Stocks Skid
Medigus Ltd.
Medigus GAAP EPS of -$0.33, revenue of $53.39M
Medigus to Increase its Share in AI Systems to 36%
See More Headlines
Receive MDGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medigus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/27/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:MDGS
Employees
77
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$110.28 million
Book Value
$51.82 per share

Miscellaneous

Free Float
1,622,000
Market Cap
$4.51 million
Optionable
Optionable
Beta
0.35
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Liron Carmel (Age 39)
    Chief Executive Officer
    Comp: $318k
  • Ms. Tali Dinar (Age 53)
    Chief Financial Officer
    Comp: $172k
  • Dr. Yaron Silberman (Age 54)
    Chief Executive Officer of ScoutCam Ltd.
    Comp: $172k
  • Ilan Oren
    Executive Officer














MDGS Stock Analysis - Frequently Asked Questions

Should I buy or sell Medigus stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medigus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDGS shares.
View MDGS analyst ratings
or view top-rated stocks.

How have MDGS shares performed in 2024?

Medigus' stock was trading at $3.26 on January 1st, 2024. Since then, MDGS stock has decreased by 16.6% and is now trading at $2.72.
View the best growth stocks for 2024 here
.

When is Medigus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our MDGS earnings forecast
.

Is Medigus a good dividend stock?

Medigus (NASDAQ:MDGS) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for MDGS.

When did Medigus' stock split?

Medigus's stock reverse split before market open on Monday, November 14th 2022. The 1-15 reverse split was announced on Monday, November 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, November 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Medigus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medigus investors own include Bombardier (BDRBF), Advanced Micro Devices (AMD), Nuwellis (CHFS), Gevo (GEVO), Genius Brands International (GNUS), IntelGenx Technologies (IGXT), Inseego (INSG), Miragen Therapeutics (MGEN) and Naked Brand Group (NAKD).

Who are Medigus' major shareholders?

Medigus' stock is owned by many different institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Medigus?

Shares of MDGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MDGS) was last updated on 2/28/2024 by MarketBeat.com Staff